Pelthos Therapeutics
Price & Volume
Stats
See moreOpen | $25 |
Previous Close | $25 |
Day Range | $24.99-$25.25 |
52W Range | $9-$37.50 |
Market Cap | $84.1M |
Shares Short | 45,956 |
Financials
See moreRevenue (12 Mos) | $16.7M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $11.5M |
Diluted EPS | -$23.04 |
News
See moreYahoo Finance • 12 hours ago
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Yahoo Finance • 21 days ago
Pelthos Therapeutics Announces CFO Transition
Yahoo Finance • 2 months ago
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag
Yahoo Finance • 4 months ago
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
About
CEO | Mr. Scott M. Plesha |
CFO | Mr. John M. Gay CPA |
Address | 4020 Stirrup Creek Drive, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 92 |